.png
)
When a new drug enters the market, it brings with it both hope and uncertainty. Clinical trials, despite their scientific rigor, are limited in scope — they can’t predict how a drug will behave in real-world conditions, across varied patient…
In the pharmaceutical industry, where precision, safety, and compliance are non-negotiable, maintaining a strong Quality Management System (QMS) isn’t just good practice—it’s a regulatory obligation. One of the most effective ways to strengthen your QMS and ensure compliance is through…
In the pharmaceutical world, Adverse Drug Reactions (ADRs) are not just unfortunate events — they’re regulatory red flags, patient safety threats, and potential business disasters. Why is this so critical? Because a single overlooked ADR can lead to product…
March 21, 2025 Central Drugs Standard Control Organization, Government of India has been mandated to ensure that the drugs being manufactured and imported into the country meet the standards of quality, safety and efficacy. This has led to the Government…
India’s pharmaceutical industry is a global powerhouse, contributing billions of dollars annually and employing millions of people. However, the regulatory landscape governing this thriving sector often feels like a maze to drug marketers. Governed primarily by the Drugs and…